Market Cap 749.13M
Revenue (ttm) 0.00
Net Income (ttm) -54.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.60
Volume 1,461,900
Avg Vol 1,435,400
Day's Range N/A - N/A
Shares Out 102.90M
Stochastic %K 3%
Beta 2.25
Analysts Strong Sell
Price Target $14.00

Company Profile

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothel...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 210 2217
Address:
22722 29th Dr. SE, Suite 100, Bothell, United States
Ghostrider2020
Ghostrider2020 Sep. 11 at 6:21 PM
$ACHV ACHV's strategy regarding the CNPV is unclear at best. I would also say the future of the CNPV program is dubious based on various health care policy analyst’s take on the new FDA commissioner nominee. However, the CEO is laser focused on getting approved and launching next year in smoking cessation. The stock becomes margin eligible on 9/22 if I'm nort mistaken and I will be buying more at that point. Maybe for a trade, can't say at this point.
1 · Reply
MasterChiefCov
MasterChiefCov Sep. 11 at 3:18 PM
$ACHV I’ll be buying more here.
0 · Reply
bobtheknob
bobtheknob Sep. 10 at 9:22 PM
$ACHV Hopefully the 50 day holds as support, it has so far since the breakout in May.
0 · Reply
moneyloser4326
moneyloser4326 Sep. 9 at 11:26 PM
$ACHV Shorts working to trick gullible investors out of their shares. There is no secondary offering coming, proxy language on the authorized share increase tied directly to the warrants overhang makes that crystal clear.
0 · Reply
CDCcsd
CDCcsd Sep. 8 at 9:42 PM
$ACHV Secondary coming? Otherwise, a buy on more weakness. I'm not selling until next year. I think this stock is derisked.
1 · Reply
jkluv
jkluv Sep. 4 at 7:51 PM
$ACHV I first bought this stock on June 30, 2020. Someday, I'll go back and see how much I've made from it, but it's been very good to me. I remember the two days in July of 2020, when I showed my co-workers and friends that I bought 16000 shares on July 30 at mostly 64 cents or less, and sold it all the next morning (premarket) for $17 a share. It was fun to see them do the math and think I made over a quarter of a million dollars in less than a day. In reality, I made 3,726.68 overnight. There was a 20-1 reverse split that night. The $17 was really equal to .85. :) That pre-market was bizzare. I had to call in to sell, because the website was crashing. When I first logged on, the price was $21 (1.05). But it was down to 17 by the time I was able to sell through an agent. Anyway, I've always believed in this stock, but it had to go through all the trial phases first. For 2026, it's Just Hold Baby! Im sitting here at a $4.12 average and just waiting.
1 · Reply
SammyD83
SammyD83 Sep. 4 at 5:52 PM
0 · Reply
focafoca99
focafoca99 Sep. 3 at 11:46 PM
$ACHV granted stock options and RSU awards to seven new employees under its 2024 Equity Inducement Plan.
0 · Reply
bobtheknob
bobtheknob Sep. 3 at 10:09 AM
$ACHV One of the blunders with Achieve is not raising cash sooner to have launched the Phase 3 vaping trial in time to meet the deadline for the CNPV. The voucher expires October 17, 2027. If they launch the trial this month, there is a narrow window to make it. There is a 60-day presubmission rule in which the voucher can be triggered by submitting nonclinical, draft labeling, and CMC in June/July 2027. if we miss out on CNPV(1-2 month review) we still have Breakthrough Therapy Designation that is a 6 month review.
3 · Reply
HappyMonster
HappyMonster Sep. 3 at 4:54 AM
$ACHV seems like such a no-brainer to me
0 · Reply
Latest News on ACHV
Achieve Life Sciences Earnings release: Q2 2026

Aug 11, 2026, 4:00 PM EDT - 4 weeks ago

Achieve Life Sciences Earnings release: Q2 2026


Achieve Life Sciences Quarterly report: Q2 2026

Aug 11, 2026, 4:00 PM EDT - 4 weeks ago

Achieve Life Sciences Quarterly report: Q2 2026


Achieve Life Sciences reports Q2 EPS (80c), consensus (16c)

2026-08-11T12:55:35.000Z - 4 weeks ago

Achieve Life Sciences reports Q2 EPS (80c), consensus (16c)


Achieve Life Sciences Transcript: AGM 2026

Jul 2, 2026, 12:00 PM EDT - 2 months ago

Achieve Life Sciences Transcript: AGM 2026


Achieve Life Sciences added to Russell 2000 Index

2026-06-29T13:00:47.000Z - 2 months ago

Achieve Life Sciences added to Russell 2000 Index


Achieve Life Sciences Joins Russell 2000® Index

Jun 29, 2026, 8:30 AM EDT - 2 months ago

Achieve Life Sciences Joins Russell 2000® Index


Achieve Life Sciences Proxy statement: Proxy filing

Jun 8, 2026, 8:00 AM EDT - 3 months ago

Achieve Life Sciences Proxy statement: Proxy filing


Achieve Life Sciences Proxy statement: Proxy filing

May 29, 2026, 8:00 AM EDT - 3 months ago

Achieve Life Sciences Proxy statement: Proxy filing


Achieve Life Sciences Earnings Call Transcript: Q1 2026

May 12, 2026, 8:30 AM EDT - 4 months ago

Achieve Life Sciences Earnings Call Transcript: Q1 2026


Achieve Life Sciences Earnings release: Q1 2026

May 12, 2026, 8:30 AM EDT - 4 months ago

Achieve Life Sciences Earnings release: Q1 2026


Achieve Life Sciences Quarterly report: Q1 2026

May 12, 2026, 8:30 AM EDT - 4 months ago

Achieve Life Sciences Quarterly report: Q1 2026


Achieve Life Sciences reports Q1 EPS (19c), consensus (30c)

2026-05-12T11:58:27.000Z - 4 months ago

Achieve Life Sciences reports Q1 EPS (19c), consensus (30c)


Achieve Life Sciences Slides: Corporate presentation

May 1, 2026, 7:00 AM EDT - 4 months ago

Achieve Life Sciences Slides: Corporate presentation


Achieve Life Sciences initiated with a Buy at Canaccord

2026-04-21T09:20:14.000Z - 4 months ago

Achieve Life Sciences initiated with a Buy at Canaccord


Achieve Life Sciences initiated with a Buy at Canaccord

2026-04-20T20:46:40.000Z - 4 months ago

Achieve Life Sciences initiated with a Buy at Canaccord


Achieve Life Sciences announces $354M private placement

2026-04-16T15:25:18.000Z - 5 months ago

Achieve Life Sciences announces $354M private placement


Achieve Life Sciences Earnings Call Transcript: Q4 2025

Mar 24, 2026, 8:30 AM EDT - 5 months ago

Achieve Life Sciences Earnings Call Transcript: Q4 2025


Achieve Life Sciences Annual report: Q4 2025

Mar 24, 2026, 8:30 AM EDT - 5 months ago

Achieve Life Sciences Annual report: Q4 2025


Achieve Life Sciences Earnings release: Q4 2025

Mar 24, 2026, 8:30 AM EDT - 5 months ago

Achieve Life Sciences Earnings release: Q4 2025


Achieve Life Sciences reports Q4 EPS (28c), consensus (28c)

2026-03-24T11:10:44.000Z - 5 months ago

Achieve Life Sciences reports Q4 EPS (28c), consensus (28c)


Aeon Biopharma appoints John Bencich as CFO

2026-03-09T20:45:55.000Z - 6 months ago

Aeon Biopharma appoints John Bencich as CFO

AEON


Achieve Life Sciences Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 8 months ago

Achieve Life Sciences Slides: Corporate presentation


Achieve Life Sciences Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Achieve Life Sciences Earnings Call Transcript: Q3 2025


Achieve Life Sciences Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Achieve Life Sciences Quarterly report: Q3 2025


Achieve Life Sciences Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Achieve Life Sciences Earnings release: Q3 2025


Achieve Life Sciences Slides: Corporate Presentation

Nov 5, 2025, 7:00 AM EST - 10 months ago

Achieve Life Sciences Slides: Corporate Presentation


Achieve Life Sciences Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings Call Transcript: Q2 2025


Achieve Life Sciences Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Quarterly report: Q2 2025


Achieve Life Sciences Earnings release: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings release: Q2 2025


Achieve Life Sciences Slides: Corporate Presentation

Aug 6, 2025, 6:00 PM EDT - 1 year ago

Achieve Life Sciences Slides: Corporate Presentation


Achieve Life Sciences Slides: Corporate Presentation

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Slides: Corporate Presentation


Achieve Life Sciences Earnings Call Transcript: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings Call Transcript: Q1 2025


Achieve Life Sciences Quarterly report: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Quarterly report: Q1 2025


Achieve Life Sciences Earnings release: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings release: Q1 2025


Achieve Life Sciences Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Proxy statement: Proxy Filing


Achieve Life Sciences Earnings Call Transcript: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings Call Transcript: Q4 2024


Achieve Life Sciences Annual report: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Annual report: Q4 2024


Achieve Life Sciences Earnings release: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings release: Q4 2024


Ghostrider2020
Ghostrider2020 Sep. 11 at 6:21 PM
$ACHV ACHV's strategy regarding the CNPV is unclear at best. I would also say the future of the CNPV program is dubious based on various health care policy analyst’s take on the new FDA commissioner nominee. However, the CEO is laser focused on getting approved and launching next year in smoking cessation. The stock becomes margin eligible on 9/22 if I'm nort mistaken and I will be buying more at that point. Maybe for a trade, can't say at this point.
1 · Reply
MasterChiefCov
MasterChiefCov Sep. 11 at 3:18 PM
$ACHV I’ll be buying more here.
0 · Reply
bobtheknob
bobtheknob Sep. 10 at 9:22 PM
$ACHV Hopefully the 50 day holds as support, it has so far since the breakout in May.
0 · Reply
moneyloser4326
moneyloser4326 Sep. 9 at 11:26 PM
$ACHV Shorts working to trick gullible investors out of their shares. There is no secondary offering coming, proxy language on the authorized share increase tied directly to the warrants overhang makes that crystal clear.
0 · Reply
CDCcsd
CDCcsd Sep. 8 at 9:42 PM
$ACHV Secondary coming? Otherwise, a buy on more weakness. I'm not selling until next year. I think this stock is derisked.
1 · Reply
jkluv
jkluv Sep. 4 at 7:51 PM
$ACHV I first bought this stock on June 30, 2020. Someday, I'll go back and see how much I've made from it, but it's been very good to me. I remember the two days in July of 2020, when I showed my co-workers and friends that I bought 16000 shares on July 30 at mostly 64 cents or less, and sold it all the next morning (premarket) for $17 a share. It was fun to see them do the math and think I made over a quarter of a million dollars in less than a day. In reality, I made 3,726.68 overnight. There was a 20-1 reverse split that night. The $17 was really equal to .85. :) That pre-market was bizzare. I had to call in to sell, because the website was crashing. When I first logged on, the price was $21 (1.05). But it was down to 17 by the time I was able to sell through an agent. Anyway, I've always believed in this stock, but it had to go through all the trial phases first. For 2026, it's Just Hold Baby! Im sitting here at a $4.12 average and just waiting.
1 · Reply
SammyD83
SammyD83 Sep. 4 at 5:52 PM
0 · Reply
focafoca99
focafoca99 Sep. 3 at 11:46 PM
$ACHV granted stock options and RSU awards to seven new employees under its 2024 Equity Inducement Plan.
0 · Reply
bobtheknob
bobtheknob Sep. 3 at 10:09 AM
$ACHV One of the blunders with Achieve is not raising cash sooner to have launched the Phase 3 vaping trial in time to meet the deadline for the CNPV. The voucher expires October 17, 2027. If they launch the trial this month, there is a narrow window to make it. There is a 60-day presubmission rule in which the voucher can be triggered by submitting nonclinical, draft labeling, and CMC in June/July 2027. if we miss out on CNPV(1-2 month review) we still have Breakthrough Therapy Designation that is a 6 month review.
3 · Reply
HappyMonster
HappyMonster Sep. 3 at 4:54 AM
$ACHV seems like such a no-brainer to me
0 · Reply
bobtheknob
bobtheknob Sep. 3 at 1:09 AM
$ACHV Might be an interesting day. Testing $8.50 resistance and $8 support holding up quite nicely last 2 weeks.
1 · Reply
Cheesecakelover
Cheesecakelover Aug. 31 at 1:59 PM
$ACHV i remember watching this last year when it was around $3, but never entered. What has changed since then, dear niche traders? I wonder if they could turn their trial into a hypestock like SLS
2 · Reply
FrostyOrbit
FrostyOrbit Aug. 30 at 10:14 PM
$ACHV Cash: $187M at June 30 2026 after a major financing...
0 · Reply
bobtheknob
bobtheknob Aug. 29 at 6:09 AM
$ACHV Would be nice to see a break and hold above $8.50 trading close to $10 by my birthday in mid September. We have been consolidating nicely around $8. Maybe they launch the Vaping trial by October.
1 · Reply
Deathparty
Deathparty Aug. 25 at 10:33 AM
$ACHV the drug is proven to work in helping people quit smoking and given that smoking is the #1 drug related cause of death in America, the potential for the Sales of this drug to reach $1B/year is very real. Once the drug is approved for vaping, the acquisition will happen and the price will be at least 2X what the shares are selling for now
1 · Reply
findingthestock
findingthestock Aug. 25 at 1:21 AM
$ACHV $ARDX $ETON $IOVA $SENS @aljudaia92 I see nothing wrong with how you traded You took profits or minimized losses Had those stocks had a negative outcome the stock price would have dropped a lot Many invested in Ardelyx have chased and have high averages those who got in 8,9s etc or even higher Many have been with Ardelyx for many years Even if a buyout based on their high averages and amount of time they have been invested it would not be a great return compared to the opportunity cost if traded another for same amount of time
2 · Reply
aljudaia92
aljudaia92 Aug. 24 at 6:53 PM
$ARDX Those who refuse to learn from the past rarely succeed in the future. I’ve taken my share of painful lessons and missed great opportunities because of fear. I sold $ACHV at $4 because I was worried about a CRL—then watched it surge 120%. I sold $IOVA at $1.80 after being scared off by the complexity of its treatment, along with a miserable Goldman Sachs report predicting the stock could fall to $1—then it climbed above $9. I sold $ETON at $24 because I was concerned about the new CEO and all the talk blaming her for the failure of her previous company—then ETON went on to reach $64. But I learned. I bought $SENS, ignored the endless negativity, stayed patient, and didn’t sell until I had made a 100% profit. Today, I’m doing it again. I’m buying a great company going through temporary difficulties—problems I believe it can overcome. And if the thesis plays out, I believe a 50% return in less than three months is entirely possible. There are no failures—only lessons
ENTSURGEON
ENTSURGEON Aug. 21 at 2:47 PM
$ACHV Added more on this dip
0 · Reply
Mugshot
Mugshot Aug. 21 at 9:27 AM
$ACHV 24%of float is being shorted
1 · Reply
LarryEllisonsMoustache
LarryEllisonsMoustache Aug. 20 at 11:29 PM
$ACHV , well i may finally may be proven wrong here .. i called this one a scam many times over .. christ it's been 10 years now .. i should get a chunk but i don't deserve it so won't .. cheering all yall long time bulls - get that money !
1 · Reply
SnoopDawg
SnoopDawg Aug. 20 at 3:55 AM
$ACHV venbio and the verona crew? V squared. Sounds like a key component of momentum to me.
1 · Reply
Jokerjoker
Jokerjoker Aug. 20 at 3:18 AM
$ACHV we have a lot going for us now however I can't help but feel we caught some wind from the $MRNA BO this bolds very well for us also I'm in $SLS and they also got a shot in the arm from it as well looking for sls and achv to be BO out in 18 months or less very bullish on both of them
1 · Reply